Outlook Therapeutics, Inc. | Note Agreements | Business Contracts

Amendment, dated February 10, 2023, to the Convertible Promissory Note, dated December 22, 2022, by and between the Company and Streeterville Capital, LLC (Filed With SEC on February 14, 2023)

Form of Note (Filed With SEC on December 22, 2022)

Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 16, 2021 (Filed With SEC on November 16, 2021)

Promissory Note dated November 16, 2021 (Filed With SEC on November 16, 2021)

Note Amendment dated November 16, 2021 (Filed With SEC on November 16, 2021)

Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 4, 2020 (Filed With SEC on November 6, 2020)

Promissory Note dated November 4, 2020 (Filed With SEC on November 6, 2020)

Form of Senior Secured Promissory Note (Filed With SEC on December 23, 2019)

Third Note Amendment dated June 28, 2019 (Filed With SEC on July 1, 2019)

Outlook Therapeutics, Inc. (61) | Note Agreements (9)